Neutralizing antibodies to herpesvirus types 1 and 2 in carcinoma of the cervix, carcinoma in situ and cervical dysplasia.
D000328:Adult; D000367:Age Factors; D000914:Antibodies, Viral / Q000032:analysis*; D002277:Carcinoma / Q000453:epidemiology / Q000276:immunology*; D002278:Carcinoma in Situ / Q000453:epidemiology / Q000276:immunology*; D005191:Family Characteristics; D005260:Female; D006561:Herpes Simplex / Q000276:immunology*; D006801:Humans; D007585:Jews; D008875:Middle Aged; D009500:Neutralization Tests; D011792:Quebec; D018139:Simplexvirus / Q000276:immunology*; D012959:Socioeconomic Factors; D002577:Uterine Cervical Diseases / Q000453:epidemiology / Q000276:immunology*; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000276:immunology*
D000914:Antibodies, Viral